AIC, a division of AIS Healthcare, now offers YIMMUGO®, manufactured by Kedrion Biopharma, for the treatment of primary humoral immunodeficiency in patients 2 years of age and older.
CERRITOS, Calif.--(BUSINESS WIRE)--KabaFusion, a leading provider of specialty acute and chronic home infusion therapies, today announced it has acquired the home infusion assets of Lincare, a ...
CERRITOS, Calif.--(BUSINESS WIRE)--KabaFusion, a leading provider of home infusion therapies, today announced it will expand its nationwide footprint by opening infusion care pharmacies in locations ...
"I realized there were a lot of other people across the country doing the same thing I was. So I figured I could connect with ...
HR 605/S 275 - The Medicare Home Infusion Site of Care Act - Lobbied in support of passage of the legislation to ensure Medicare beneficiaries have access to home infusion. IVIG Coverage Demonstration ...
Connie Sullivan, president and CEO of the National Home Infusion Association (NHIA), discusses why at-home infusion is beneficial to patients and why so many patients reported feeling satisfied with ...
The introduction of human immunoglobulin (Ig) therapies 40 years ago reduced the risk of often life-threatening infections for individuals with one of several immune-related conditions known as ...
A severe shortage of immune globulin - a popular medicine used to treat epilepsy, cancer and immune disorders - is forcing doctors nationwide to cancel patients' lifesaving infusions as hospitals and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback